Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
132.24
-1.07 (-0.80%)
Oct 10, 2025, 3:43 PM EDT - Market open
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $11.14B in the quarter ending June 30, 2025, with 7.37% growth. This brings the company's revenue in the last twelve months to $43.11B, up 5.85% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.
Revenue (ttm)
$43.11B
Revenue Growth
+5.85%
P/S Ratio
5.38
Revenue / Employee
$378,149
Employees
114,000
Market Cap
230.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
Dec 31, 2019 | 31.90B | 1.33B | 4.34% |
Dec 31, 2018 | 30.58B | 3.19B | 11.64% |
Dec 31, 2017 | 27.39B | 6.54B | 31.35% |
Dec 31, 2016 | 20.85B | 448.00M | 2.20% |
Dec 31, 2015 | 20.41B | 158.00M | 0.78% |
Dec 31, 2014 | 20.25B | 590.00M | 3.00% |
Dec 31, 2013 | 19.66B | 607.00M | 3.19% |
Dec 31, 2012 | 19.05B | -2.36B | -11.01% |
Dec 31, 2011 | 21.41B | -13.76B | -39.13% |
Dec 31, 2010 | 35.17B | 4.40B | 14.31% |
Dec 31, 2009 | 30.76B | 1.24B | 4.19% |
Dec 31, 2008 | 29.53B | 3.61B | 13.94% |
Dec 31, 2007 | 25.91B | 3.44B | 15.30% |
Dec 31, 2006 | 22.48B | 138.51M | 0.62% |
Dec 31, 2005 | 22.34B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ABT News
- 1 day ago - Abbott Laboratories: There May Be A Surge Coming Next Week (Earnings Preview) - Seeking Alpha
- 4 days ago - Ventric Health Appoints Managed Care Veteran Christopher Abbott to Board of Directors - Business Wire
- 12 days ago - Best Dividend Aristocrats For October 2025 - Seeking Alpha
- 16 days ago - Abbott Hosts Conference Call for Third-Quarter Earnings - PRNewsWire
- 17 days ago - These Dividend Stocks Have Big Yields and Are Beating the Odds - Barrons
- 21 days ago - Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE - Forbes
- 21 days ago - 1 Dividend King To Hold And 2 Worth Buying Now - Seeking Alpha
- 21 days ago - Abbott Declares 407th Consecutive Quarterly Dividend - PRNewsWire